Latest Corporate News
Engie Acquires UK Power Networks for $14.2 Billion
French energy giant Engie is buying UK Power Networks from Hong Kong’s CK Group in a $14.2 billion deal, highlighting strong investor focus on infrastructure and utilities. This acquisition combines significant deal size and sector emphasis on resilient assets amid global uncertainties.
Gilead Sciences to Buy Arcellx for $7.8 Billion
Gilead Sciences announced the acquisition of Arcellx, a biotech firm, for $7.8 billion, continuing consolidation in oncology and biotech sectors. The deal underscores ongoing M&A activity redefining global markets.
Brink’s Company Acquires NCR Atleos for $6.6 Billion
The Brink’s Company, a cash logistics provider, is acquiring NCR Atleos Corporation for $6.6 billion to expand into ATM-as-a-Service and enhance global financial infrastructure. This move strengthens recurring revenue streams in logistics.
BlackRock-Led Consortium Buys AES Corporation for $10.7 Billion
A BlackRock-owned consortium, including Global Infrastructure Partners, is acquiring AES Corporation for $10.7 billion in cash, potentially making the major clean energy supplier private. The deal, at $15 per share, addresses capital needs for growth amid rising US electricity demand from data centers.
Expected to close late 2026 or early 2027.
Affinius Capital and Vista Hill Partners Acquire Veris Residential for $3.4 Billion
Investor consortium led by Affinius Capital and Vista Hill Partners is buying Veris Residential for $3.4 billion to optimize its multifamily real estate portfolio. The acquisition enhances operational flexibility and long-term value creation in rising real estate privatizations.
KKR Acquires XCL for $1.3 Billion
Private equity firm KKR is acquiring XCL for $1.3 billion, reflecting private equity's targeting of stable sectors amid diverse M&A trends. This deal contributes to strong capital deployment across industries.
Antengene Grants UCB Global License for ATG-201 Autoimmune Drug
Antengene and UCB entered a global license agreement for ATG-201, a CD19/CD3 bispecific T-cell engager for B cell-related autoimmune diseases. Antengene receives $80 million upfront and near-term milestones, plus over $1.1 billion in potential milestones and royalties.
Highlights AnTenGager platform's capabilities with 9 more products in pipeline.
Amicus Therapeutics Shareholders Approve BioMarin Acquisition
Amicus Therapeutics investors overwhelmingly approved its merger with BioMarin Pharmaceutical, with US antitrust waiting period ended. Deal expected to close in Q2 2026 pending other regulatory clearances.
Strong shareholder support with over 234.5 million votes in favor.
Accel-KKR Makes Majority Investment in Whip Around
Fleet maintenance software provider Whip Around received a majority investment from Accel-KKR to accelerate growth, innovation, and market expansion. The partnership enables increased platform investments and potential acquisitions.
Announced on March 3, 2026.
STRACON Group Reports Record $2.191 Billion Year-End Backlog
STRACON Group announced a record backlog of US$2,191 million as of December 31, 2025, setting March 31, 2026, as a key reporting date. This reflects strong performance in its operations.
Global Stocks Plunge Amid Iran War and Oil Price Surge
Dow plunged 1,000 points as Iran conflict escalates, hitting shipping and causing oil prices to leap 7.5% to $83.58 per barrel Brent crude. S&P 500 and Nasdaq dropped over 2%, with airlines sinking on fuel cost fears.
Concerns rise over Strait of Hormuz impacting global oil supply.
Middle East Conflict Disrupts Trade and Boosts Resilience Focus
World Economic Forum reports Middle East escalation hitting shipping and oil, with 74% of business leaders prioritizing supply chain resilience per Global Value Chains Outlook 2026. Over 3,000 new trade measures introduced globally in 2025.
US launches $12B critical minerals reserve against China dominance.